Dosage & Administration Drug label Financial assistance PubMed™ News

Scemblix

(asciminib)

asciminib 20 MG Oral Tablet [Scemblix]asciminib 40 MG Oral Tablet [Scemblix]

NO BOXED WARNING

Dosage & administration

* Recommended Dosage in Ph+ CML in CP: 80 mg orally once daily or 40 mg twice daily.
* Recommended Dosage in Ph+ CML in CP with the T315I Mutation: 200 mg orally twice daily.
* Avoid food for at least 2 hours before and 1 hour after taking SCEMBLIX.
* Swallow tablets whole. Do not break, crush, or chew the tablets.

drug label

Scemblix prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Scemblix financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PANO Service Request Form - Patient

PANO Service Request Form - HCP

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

PubMed™ | Scemblix

Scemblix PubMed™ News

patient education

Scemblix patient education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Scemblix

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

View How to Take Scemblix

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Side Effects

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Stories

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Scemblix FAQs

How is the dosage of Scemblix?Scemblix is available in 2 dosages, including 20 mg Tab and 40 mg Tab

What does Scemblix treat?Scemblix treats Myeloid Leukemia

How Is Scemblix Administered?Scemblix is administered as a Oral Pill

FAQ Data Source

Scemblix

Dosage & administration

drug label

Scemblix prescribing information

financial assistance

Scemblix financial assistance options

Co-pay savings program

Foundation programs

PubMed™ | Scemblix

Scemblix PubMed™ News

patient education

Scemblix patient education

Patient toolkit

people also ask

Scemblix FAQs